Source:http://linkedlifedata.com/resource/pubmed/id/16056247
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2005-10-20
|
pubmed:abstractText |
This study was undertaken to determine the prognostic relevance of the proliferation rate in neoplastic cells in children and adolescents with Hodgkin's lymphoma. Paraffin-embedded biopsy specimens were immunostained with the proliferation-associated monoclonal antibodies Ki-S5 (Ki-67 antigen) and Ki-S2 (which detects the repp86 protein). Repp86 is a protein of about 100 kDa encoded by a gene located on human chromosome band 20q11.2. In contrast to the Ki-67 antigen, repp86 expression is restricted to the cell cycle phases G(2), S and M. Immunohistochemical results on diagnostic lymph node biopsy specimens from 224 patients included in two pediatric multicenter Hodgkin's trials, GPOH HD-90 and HD-95, were compared with clinical data. High Ki-67 antigen expression was a striking feature of Hodgkin's and Reed-Sternberg cells as well as lymphocytic and histiocytic cells (median: 80%, range: 20-100%), in contrast to low repp86 expression (median: 20%, range: 10-80%; P<0.001). The proliferation rate was independent of histological subtype, stage and presence of B symptoms. The probability of event-free and overall survival (+/-standard error) of all patients at 5 years was 91.6+/-2.0 and 98.1+/-1.0%, respectively. The proliferation rate of tumor cells did not influence the outcome. The difference between Ki-67 and repp86 expression in Hodgkin's and Reed-Sternberg or lymphocytic and histiocytic cells points to a possible cell cycle arrest in the G(1) phase, which may explain the obvious paradox of a highly proliferating but slowly growing paucicellular tumor. High Ki-67 expression does not seem to be an adverse prognostic factor in pediatric and adolescent patients with Hodgkin's lymphoma treated by effective risk-adapted chemo-radiotherapy regimens.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0893-3952
|
pubmed:author | |
pubmed:copyrightInfo |
Modern Pathology (2005) 18, 1440-1447. doi:10.1038/modpathol.3800466; published online 29 July 2005.
|
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1440-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16056247-Adolescent,
pubmed-meshheading:16056247-Adult,
pubmed-meshheading:16056247-Cell Proliferation,
pubmed-meshheading:16056247-Child,
pubmed-meshheading:16056247-Child, Preschool,
pubmed-meshheading:16056247-Disease-Free Survival,
pubmed-meshheading:16056247-Female,
pubmed-meshheading:16056247-G1 Phase,
pubmed-meshheading:16056247-Hodgkin Disease,
pubmed-meshheading:16056247-Humans,
pubmed-meshheading:16056247-Immunohistochemistry,
pubmed-meshheading:16056247-Ki-67 Antigen,
pubmed-meshheading:16056247-Male,
pubmed-meshheading:16056247-Nuclear Proteins,
pubmed-meshheading:16056247-Prognosis,
pubmed-meshheading:16056247-Reed-Sternberg Cells,
pubmed-meshheading:16056247-Survival Analysis
|
pubmed:year |
2005
|
pubmed:articleTitle |
Proliferation characteristics in pediatric Hodgkin's lymphoma point to a cell cycle arrest in the G(1) phase.
|
pubmed:affiliation |
Department of Hematopathology, University of Kiel, Kiel, Germany.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|